Stock Taper
HeartBeam, Inc. develops telemedicine solutions, including a portable ECG device and cloud-based software, for remote detection and monitoring of cardiac disease to aid physicians in cardiovascular patient care.

HeartBeam AIMIGo is a credit card-sized ECG device with a smartphone app, enabling remote, real-time heart attack detection and arrhythmia assessment, recently FDA-cleared for arrhythmia and under review for heart attack diagnosis.
| Icon | PRODUCT | Q4-2019 | Q1-2020 | Q2-2020 | Q3-2020 |
|---|---|---|---|---|---|
![]() | MonitoringCommercial | $55.96M | $55.58M ▼ | $41.4M ▼ | $57.05M ▲ |
![]() | MonitoringMedicare | $39.17M | $40.13M ▲ | $33.28M ▼ | $41.42M ▲ |
![]() | ClinicalTrialSupportandRelatedServices | $13.37M | $13.82M ▲ | $11.46M ▼ | $12.12M ▲ |
![]() | TechnologyDevicesConsumablesandRelatedServices | $3.54M | $3.5M ▼ | $3.27M ▼ | $4.07M ▲ |
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
SPRB | $60.78 | COMPARE |
EQ | $2.39 | COMPARE |
OTLK | $0.64 | COMPARE |
OSTX | $1.64 | COMPARE |
INKT | $11.43 | COMPARE |
MDAI | $1.57 | COMPARE |
HOWL | $0.94 | COMPARE |
ONMD | $0.58 | COMPARE |